Patents by Inventor Gordana Olbina

Gordana Olbina has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10239941
    Abstract: The present application relates to antibodies that specifically bind to hepcidin and methods of using the antibodies. Another aspect relates to antibodies which bind hepcidin and regulate iron homeostasis. Another aspect relates to the use of humanized antibodies which bind hepcidin for the treatment of a disease or condition associated with hepcidin.
    Type: Grant
    Filed: August 31, 2017
    Date of Patent: March 26, 2019
    Assignee: Intrinsic Lifesciences LLC
    Inventors: Mark Westerman, Vaughn Ostland, Huiling Han, Patrick Gutschow, Keith Westerman, Gordana Olbina
  • Publication number: 20180057586
    Abstract: The present application relates to antibodies that specifically bind to hepcidin and methods of using the antibodies. Another aspect relates to antibodies which bind hepcidin and regulate iron homeostasis. Another aspect relates to the use of humanized antibodies which bind hepcidin for the treatment of a disease or condition associated with hepcidin.
    Type: Application
    Filed: August 31, 2017
    Publication date: March 1, 2018
    Inventors: Mark Westerman, Vaughn Ostland, Huiling Han, Patrick Gutschow, Keith Westerman, Gordana Olbina
  • Patent number: 9803011
    Abstract: The present application relates to antibodies that specifically bind to hepcidin and methods of using the antibodies. Another aspect relates to antibodies which bind hepcidin and regulate iron homeostasis. Another aspect relates to the use of humanized antibodies which bind hepcidin for the treatment of a disease or condition associated with hepcidin.
    Type: Grant
    Filed: April 11, 2017
    Date of Patent: October 31, 2017
    Assignee: Intrinsic Lifesciences LLC
    Inventors: Mark Westerman, Vaughn Ostland, Huiling Han, Patrick Gutschow, Keith Westerman, Gordana Olbina
  • Publication number: 20170283495
    Abstract: The present application relates to antibodies that specifically bind to hepcidin and methods of using the antibodies. Another aspect relates to antibodies which bind hepcidin and regulate iron homeostasis. Another aspect relates to the use of humanized antibodies which bind hepcidin for the treatment of a disease or condition associated with hepcidin.
    Type: Application
    Filed: April 11, 2017
    Publication date: October 5, 2017
    Inventors: Mark WESTERMAN, Vaughn OSTLAND, Huiling HAN, Patrick GUTSCHOW, Keith WESTERMAN, Gordana OLBINA
  • Patent number: 9657098
    Abstract: The present application relates to antibodies that specifically bind to hepcidin and methods of using the antibodies. Another aspect relates to antibodies which bind hepcidin and regulate iron homeostasis. Another aspect relates to the use of humanized antibodies which bind hepcidin for the treatment of a disease or condition associated with hepcidin.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: May 23, 2017
    Assignee: INTRINSIC LIFESCIENCES, LLC
    Inventors: Mark Westerman, Vaughn Ostland, Huiling Han, Patrick Gutschow, Keith Westerman, Gordana Olbina
  • Publication number: 20160017032
    Abstract: The present application relates to antibodies that specifically bind to hepcidin and methods of using the antibodies. Another aspect relates to antibodies which bind hepcidin and regulate iron homeostasis. Another aspect relates to the use of humanized antibodies which bind hepcidin for the treatment of a disease or condition associated with hepcidin.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 21, 2016
    Inventors: Mark Westerman, Vaughn Ostland, Huiling Han, Patrick Gutschow, Keith Westerman, Gordana Olbina
  • Patent number: 6017898
    Abstract: Oligonucleotides are provided which are effective in inhibiting the growth, metastasis and/or angiogenesis of tumors, including particularly melanoma and/or lung cancer. Methods are also provided for use of these oligonucleotides in the treatment of diseases.
    Type: Grant
    Filed: April 6, 1998
    Date of Patent: January 25, 2000
    Assignee: ICN Pharmaceuticals, Inc.
    Inventors: Zbigniew Pietrzkowski, Dariusz Cieslak, Gordana Olbina
  • Patent number: 5849903
    Abstract: Oligonucleotides are provided which are effective in inhibiting the growth, metastasis and/or angiogenesis of tumors, including particularly melanoma and/or lung cancer. Methods are also provided for use of these oligonucleotides in the treatment of diseases.
    Type: Grant
    Filed: February 5, 1997
    Date of Patent: December 15, 1998
    Assignee: ICN Pharmaceuticals, Inc.
    Inventors: Zbigniew Pietrzkowski, Dariusz Cieslak, Gordana Olbina